TFS Chemicals - Aspire
Pharma Focus America
Sino Biological - Cytokine

ChemDiv and The University of Texas Medical Branch (UTMB) Form Strategic Alliance to Enhance High-throughput Screening Research Capabilities

Friday, December 29, 2023

ChemDiv, a leading player in the field of drug discovery solutions worldwide, has recently announced a strategic collaboration with the University of Texas Medical Branch (UTMB) to support the expansion of its inventory and advance the institution's High-throughput Screening (HTS) research programs.

ChemDiv's comprehensive suite of fully integrated Research & Development services will provide UTMB with unprecedented support in its pursuit of groundbreaking medical research. Leveraging ChemDiv's 32 years of experience, advanced capabilities, and a seasoned team of experts, UTMB aims to push the boundaries of medical research and translate discoveries into tangible treatments for urgent medical needs.

Bill Farley, CEO of ChemDiv, emphasized the company's dedication to catalyzing innovative research. He stated that the collaboration with UTMB exemplifies their commitment to advancing global healthcare. Farley highlighted that ChemDiv's team expertise and cutting-edge resources are poised to significantly enhance UTMB's HTS research center, expediting the discovery of novel therapeutic solutions.



patheon - Mastering API production at every scaleWorld Vaccine Congress Europe 2024World Orphan Drug Congress 2024Future Labs Live USA 2024patheon - Revolutionizing PharmaHealthcare CNO SummitHealthcare CMO Summit